James E. Cleaver

Active 1967–2021

Affiliations
University of California San Francisco Medical CenterUniversity of California, San FranciscoThis corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
73
Papers
14,836
Citations
69
h-index
73
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for James E. Cleaver1968: 5 citations1969: 19 citations1970: 28 citations1971: 52 citations1972: 62 citations1973: 63 citations1974: 102 citations1975: 47 citations1976: 60 citations1977: 88 citations1978: 71 citations1979: 86 citations1980: 41 citations1981: 50 citations1982: 38 citations1983: 31 citations1984: 25 citations1985: 30 citations1986: 21 citations1987: 27 citations1988: 24 citations1989: 22 citations1990: 30 citations1991: 20 citations1992: 31 citations1993: 47 citations1994: 41 citations1995: 49 citations1996: 44 citations1997: 42 citations1998: 37 citations1999: 52 citations2000: 63 citations2001: 69 citations2002: 71 citations2003: 81 citations2004: 52 citations2005: 66 citations2006: 61 citations2007: 53 citations2008: 76 citations2009: 51 citations2010: 55 citations2011: 60 citations2012: 89 citations2013: 92 citations2014: 70 citations2015: 58 citations2016: 84 citations2017: 62 citations2018: 59 citations2019: 150 citations2020: 156 citations2021: 160 citations2022: 104 citations2023: 89 citations2024: 99 citations2025: 41 citations

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Fields

  • Biochemistry, Genetics and Molecular Biology62.7%
  • Medicine29%
  • Agricultural and Biological Sciences2%
  • Neuroscience1.2%
  • Immunology and Microbiology1.2%
  • Environmental Science1.1%
  • Other2.8%

Topics

  • DNA Repair Mechanisms33.2%
  • Carcinogens and Genotoxicity Assessment13.4%
  • DNA and Nucleic Acid Chemistry6.3%
  • CRISPR and Genetic Engineering6.1%
  • Cancer-related Molecular Pathways5.6%
  • Cancer Genomics and Diagnostics4.9%
  • Other30.4%

Frequent coauthors

All papers

Loading papers…

James E. Cleaver | Litlas